Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Larimar Therapeutics, Inc. | 125,000 | reported | 22 Jan 2019 | tx 8+522,000 |
| ALNYLAM PHARMACEUTICALS, INC. | 25,000 | reported | 08 Dec 2010 | tx 61+204,288−65,000 |
| Zenas BioPharma, Inc. | 19,860 | reported | 13 Feb 2026 | tx 6+56,860 |
| PROTEOSTASIS THERAPEUTICS, INC. | 14,800 | reported | 02 Jun 2021 | tx 3+32,566 |
| Deciphera Pharmaceuticals, Inc. | 0 | reported | 11 Jun 2024 | tx 32+218,480−151,987 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Feb 2026 | PURCHASE | Zenas BioPharma, Inc. | 5,700 | 24.34 USD | |
| 12 Feb 2026 | PURCHASE | Zenas BioPharma, Inc. | 5,000 | 23.77 USD | |
| 13 Feb 2026 | PURCHASE | Zenas BioPharma, Inc. | 4,160 | 26.36 USD | |
| 12 Feb 2026 | PURCHASE | Zenas BioPharma, Inc. | 5,000 | 26.50 USD | first after silence |
| 10 Jun 2025 | GRANT_AWARD | Zenas BioPharma, Inc. | 18,500 | 0.00 USD | deriv |
| 12 Sept 2024 | GRANT_AWARD | Zenas BioPharma, Inc. | 18,500 | 0.00 USD | deriv |
| 11 Jun 2024 | OTHER | Deciphera Pharmaceuticals, Inc. | 10,233 | — | deriv |
| 11 Jun 2024 | OTHER | Deciphera Pharmaceuticals, Inc. | 7,181 | — | deriv |
| 11 Jun 2024 | OTHER | Deciphera Pharmaceuticals, Inc. | 12,000 | — | deriv |
| 11 Jun 2024 | OTHER | Deciphera Pharmaceuticals, Inc. | 4,727 | — | deriv |
| 11 Jun 2024 | OTHER | Deciphera Pharmaceuticals, Inc. | 18,500 | — | deriv |
| 11 Jun 2024 | OTHER | Deciphera Pharmaceuticals, Inc. | 3,269 | — | deriv |
| 11 Jun 2024 | OTHER | Deciphera Pharmaceuticals, Inc. | 30,000 | — | deriv |
| 11 Jun 2024 | OTHER | Deciphera Pharmaceuticals, Inc. | 9,570 | — | deriv |
| 16 Jan 2024 | GRANT_AWARD | Deciphera Pharmaceuticals, Inc. | 4,727 | 10.58 USD | deriv |
| 21 Jun 2023 | GRANT_AWARD | Deciphera Pharmaceuticals, Inc. | 30,000 | 0.00 USD | deriv |
| 17 Jan 2023 | GRANT_AWARD | Deciphera Pharmaceuticals, Inc. | 3,269 | 15.30 USD | deriv |
| 23 Jun 2022 | GRANT_AWARD | Deciphera Pharmaceuticals, Inc. | 18,500 | 0.00 USD | deriv |
| 18 Jan 2022 | GRANT_AWARD | Deciphera Pharmaceuticals, Inc. | 9,570 | 5.22 USD | deriv |
| 23 Jun 2021 | GRANT_AWARD | Deciphera Pharmaceuticals, Inc. | 12,000 | 0.00 USD | deriv |
| 02 Jun 2021 | GRANT_AWARD | PROTEOSTASIS THERAPEUTICS, INC. | 14,800 | 0.00 USD | deriv |
| 22 Dec 2020 | GRANT_AWARD | PROTEOSTASIS THERAPEUTICS, INC. | 12,495 | — | deriv |
| 22 Dec 2020 | GRANT_AWARD | PROTEOSTASIS THERAPEUTICS, INC. | 5,271 | — | deriv |
| 10 Jun 2020 | GRANT_AWARD | Deciphera Pharmaceuticals, Inc. | 12,000 | 0.00 USD | deriv |
| 03 Jun 2020 | EXERCISE | Deciphera Pharmaceuticals, Inc. | 6,365 | 25.73 USD |
1 purchase reported after at least 12 months of silence — most recent on 12 Feb 2026.